Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maxime Dougados

Showing results (431-440 of 600) with videos related to

Pageof 60
Sort By:
RMD Open|November 30, 2018
Uncovering the heterogeneity of disease impact in axial spondyloarthritis: bivariate trajectories of disease activity and quality of lifeMaike Imkamp, Valéria Lima Passos, Annelies Boonen, et al.
Annals of the Rheumatic Diseases|October 18, 2017
An Assessment in SpondyloArthritis International Society (ASAS)-endorsed definition of clinically important worsening in axial spondyloarthritis based on ASDASAnna Molto, Laure Gossec, Bhowmik Meghnathi, et al.
The New England Journal of Medicine|September 16, 2005
Abatacept for rheumatoid arthritis refractory to tumor necrosis factor alpha inhibitionMark C Genovese, Jean-Claude Becker, Michael Schiff, et al.
Arthritis Care & Research|January 13, 2015
Development of multinational definitions of minimal clinically important improvement and patient acceptable symptomatic state in osteoarthritisNicholas Bellamy, Marc Hochberg, Florence Tubach, et al.
Arthritis Research & Therapy|September 25, 2016
Rheumatology training experience across Europe: analysis of core competencesFrancisca Sivera, Sofia Ramiro, Nada Cikes, et al.
The Journal of Rheumatology|February 15, 2024
Erosions on T1-Weighted Magnetic Resonance Imaging Versus Radiography of Sacroiliac Joints in Recent-Onset Axial Spondyloarthritis: 2-Year Data (EMBARK Trial and DESIR Cohort)Walter P Maksymowych, Pascal Claudepierre, Manouk de Hooge, et al.
Rheumatology (Oxford, England)|October 3, 2024
Prevalence and incidence of uveitis in patients with spondyloarthritis: the impact of the biologics era. Data from the international ASAS-COMOSPA studyHernán Maldonado-Ficco, Clementina López-Medina, Rodolfo Perez-Alamino, et al.
Arthritis Research & Therapy|January 30, 2021
Structural changes in the sacroiliac joint on MRI and relationship to ASDAS inactive disease in axial spondyloarthritis: a 2-year study comparing treatment with etanercept in EMBARK to a contemporary control cohort in DESIRWalter P Maksymowych, Pascal Claudepierre, Manouk de Hooge, et al.
Annals of the Rheumatic Diseases|May 9, 2020
Maintenance of clinical remission in early axial spondyloarthritis following certolizumab pegol dose reductionRobert Bm Landewé, Désirée van der Heijde, Maxime Dougados, et al.
Joint Bone Spine|December 17, 2017
An e-health interactive self-assessment website (Sanoia<sup>®</sup>) in rheumatoid arthritis. A 12-month randomized controlled trial in 320 patientsLaure Gossec, Alain Cantagrel, Martin Soubrier, et al.
Pageof 60

Showing results (431-440 of 600) with videos related to

Sort By:
Pageof 60
RMD Open|November 30, 2018
Uncovering the heterogeneity of disease impact in axial spondyloarthritis: bivariate trajectories of disease activity and quality of lifeMaike Imkamp, Valéria Lima Passos, Annelies Boonen, et al.
Annals of the Rheumatic Diseases|October 18, 2017
An Assessment in SpondyloArthritis International Society (ASAS)-endorsed definition of clinically important worsening in axial spondyloarthritis based on ASDASAnna Molto, Laure Gossec, Bhowmik Meghnathi, et al.
The New England Journal of Medicine|September 16, 2005
Abatacept for rheumatoid arthritis refractory to tumor necrosis factor alpha inhibitionMark C Genovese, Jean-Claude Becker, Michael Schiff, et al.
Arthritis Care & Research|January 13, 2015
Development of multinational definitions of minimal clinically important improvement and patient acceptable symptomatic state in osteoarthritisNicholas Bellamy, Marc Hochberg, Florence Tubach, et al.
Arthritis Research & Therapy|September 25, 2016
Rheumatology training experience across Europe: analysis of core competencesFrancisca Sivera, Sofia Ramiro, Nada Cikes, et al.
The Journal of Rheumatology|February 15, 2024
Erosions on T1-Weighted Magnetic Resonance Imaging Versus Radiography of Sacroiliac Joints in Recent-Onset Axial Spondyloarthritis: 2-Year Data (EMBARK Trial and DESIR Cohort)Walter P Maksymowych, Pascal Claudepierre, Manouk de Hooge, et al.
Rheumatology (Oxford, England)|October 3, 2024
Prevalence and incidence of uveitis in patients with spondyloarthritis: the impact of the biologics era. Data from the international ASAS-COMOSPA studyHernán Maldonado-Ficco, Clementina López-Medina, Rodolfo Perez-Alamino, et al.
Arthritis Research & Therapy|January 30, 2021
Structural changes in the sacroiliac joint on MRI and relationship to ASDAS inactive disease in axial spondyloarthritis: a 2-year study comparing treatment with etanercept in EMBARK to a contemporary control cohort in DESIRWalter P Maksymowych, Pascal Claudepierre, Manouk de Hooge, et al.
Annals of the Rheumatic Diseases|May 9, 2020
Maintenance of clinical remission in early axial spondyloarthritis following certolizumab pegol dose reductionRobert Bm Landewé, Désirée van der Heijde, Maxime Dougados, et al.
Joint Bone Spine|December 17, 2017
An e-health interactive self-assessment website (Sanoia<sup>®</sup>) in rheumatoid arthritis. A 12-month randomized controlled trial in 320 patientsLaure Gossec, Alain Cantagrel, Martin Soubrier, et al.
Pageof 60